Literature DB >> 25211232

Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis.

D B Zhen1, P L Swiecicki1, S R Zeldenrust2, A Dispenzieri2, M L Mauermann3, M A Gertz2.   

Abstract

Inherited forms of amyloidosis are rare; of these, transthyretin-related (ATTR) is the most common, but non-ATTR has been described as well. We studied a large case series of ATTR and a small series of non-ATTR to better determine the mutation frequencies and geographic distributions of these inherited forms of amyloidosis in the United States. We performed a retrospective cross-sectional study of 284 ATTR and non-ATTR patients seen at Mayo Clinic in Rochester, Minnesota, from 1 January 1970 through 29 January 2013. Mutations were identified by DNA sequencing, restriction fragment length polymorphism, or mass spectroscopy. The genetic testing method was unknown for several patients, but a small proportion were identified by family history or by classical clinical presentation associated with a specific mutation. The most common ATTR mutations were Thr60Ala (24%), Val30Met (15%), Val122Ile (10%), and Ser77Tyr (5%). Non-ATTR mutations included gelsolin (n = 3), apolipoprotein A-I (n = 6), apolipoprotein A-II (n = 1), fibrinogen A-α (n = 9), and lysozyme (n = 1). Although rare, ATTR and, to a lesser extent, non-ATTR are prevalent in the United States and should be considered for patients presenting in the appropriate clinical context.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  amyloidosis; apolipoprotein; fibrinogen; gelsolin; hereditary; lysozyme; mutation; transthyretin

Mesh:

Substances:

Year:  2014        PMID: 25211232     DOI: 10.1111/cge.12500

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

Authors:  Mathew S Maurer; Mazen Hanna; Martha Grogan; Angela Dispenzieri; Ronald Witteles; Brian Drachman; Daniel P Judge; Daniel J Lenihan; Stephen S Gottlieb; Sanjiv J Shah; D Eric Steidley; Hector Ventura; Srinivas Murali; Marc A Silver; Daniel Jacoby; Savitri Fedson; Scott L Hummel; Arnt V Kristen; Thibaud Damy; Violaine Planté-Bordeneuve; Teresa Coelho; Rajiv Mundayat; Ole B Suhr; Márcia Waddington Cruz; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2016-07-12       Impact factor: 24.094

2.  Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan.

Authors:  Hua-Chuan Chao; Yi-Chu Liao; Yo-Tsen Liu; Yuh-Cherng Guo; Fu-Pang Chang; Yi-Chung Lee; Kon-Ping Lin
Journal:  Ann Clin Transl Neurol       Date:  2019-04-09       Impact factor: 4.511

Review 3.  Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis.

Authors:  Imad Bentellis; Gérard Amarenco; Xavier Gamé; Dora Jericevic; Mehdi El-Akri; Caroline Voiry; Lucas Freton; Juliette Hascoet; Quentin Alimi; Jacques Kerdraon; Benjamin M Brucker; Benoit Peyronnet
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

4.  Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.

Authors:  Kang Du; Fan Li; Hui Wang; Yuanfeng Miao; He Lv; Wei Zhang; Zhaoxia Wang; Yun Yuan; Lingchao Meng
Journal:  Ann Clin Transl Neurol       Date:  2021-03-19       Impact factor: 4.511

5.  Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.

Authors:  Maria S Saez; Maria A Aguirre; Diego Pérez de Arenaza; Patricia Sorroche; Elsa Nucifora; Maria L Posadas Martinez
Journal:  Mol Genet Genomic Med       Date:  2021-10-20       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.